Florida OTC Manufacturer Hit for Quality, Water System Deficiencies

Drug Industry Daily
A A
The FDA cited Debut Development for inadequate quality and water system procedures at its Wauchula, Florida OTC drugmaking facility.

To View This Article:

Login

Subscribe To Drug Industry Daily